Chandra Bhagat Pharma Limited (BOM:542934)
India
· Delayed Price · Currency is INR 58.00
0.00 (0.00%)
At close: Jun 19, 2025
Chandra Bhagat Pharma Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2020 |
Operating Revenue | 867.16 | 2,214 | 1,197 | 940.76 | 706.95 | Upgrade
|
Other Revenue | - | 11.3 | - | - | 0.02 | Upgrade
|
| 867.16 | 2,225 | 1,197 | 940.76 | 706.97 | Upgrade
| |
Revenue Growth (YoY) | -61.03% | 85.93% | 27.21% | 33.07% | -24.78% | Upgrade
|
Cost of Revenue | 732.81 | 2,083 | 1,068 | 814.41 | 598.3 | Upgrade
|
Gross Profit | 134.35 | 142.31 | 129.04 | 126.34 | 108.67 | Upgrade
|
Selling, General & Admin | 25.09 | 29.68 | 18.25 | 21.31 | 25.1 | Upgrade
|
Other Operating Expenses | 68.62 | 74.53 | 71.48 | 52.63 | 38.16 | Upgrade
|
Operating Expenses | 103.22 | 110.63 | 92.39 | 75.18 | 64.46 | Upgrade
|
Operating Income | 31.13 | 31.69 | 36.66 | 51.17 | 44.21 | Upgrade
|
Interest Expense | -19.48 | -12.87 | -21.75 | -29.84 | -35.55 | Upgrade
|
Interest & Investment Income | - | 0.07 | 0.03 | 1.54 | 0.66 | Upgrade
|
Currency Exchange Gain (Loss) | - | 7.7 | -0.61 | -9.29 | -3.59 | Upgrade
|
Other Non Operating Income (Expenses) | - | -1 | -0.23 | -2.53 | -2.03 | Upgrade
|
EBT Excluding Unusual Items | 11.65 | 25.58 | 14.09 | 11.05 | 3.71 | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | 0.01 | - | - | Upgrade
|
Pretax Income | 11.65 | 25.58 | 14.11 | 11.05 | 3.71 | Upgrade
|
Income Tax Expense | 3.08 | 10.28 | 5.05 | 3.08 | 1.81 | Upgrade
|
Net Income | 8.58 | 15.3 | 9.05 | 7.97 | 1.9 | Upgrade
|
Net Income to Common | 8.58 | 15.3 | 9.05 | 7.97 | 1.9 | Upgrade
|
Net Income Growth | -43.95% | 69.02% | 13.64% | 319.54% | -39.67% | Upgrade
|
Shares Outstanding (Basic) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
Shares Outstanding (Diluted) | 8 | 8 | 8 | 8 | 8 | Upgrade
|
Shares Change (YoY) | -0.27% | - | - | - | 31.87% | Upgrade
|
EPS (Basic) | 1.14 | 2.03 | 1.20 | 1.06 | 0.25 | Upgrade
|
EPS (Diluted) | 1.14 | 2.03 | 1.20 | 1.06 | 0.25 | Upgrade
|
EPS Growth | -43.79% | 69.02% | 13.64% | 322.37% | -54.55% | Upgrade
|
Free Cash Flow | -69.11 | 38.94 | 48.96 | 122.99 | 83.08 | Upgrade
|
Free Cash Flow Per Share | -9.19 | 5.16 | 6.49 | 16.30 | 11.01 | Upgrade
|
Gross Margin | 15.49% | 6.40% | 10.78% | 13.43% | 15.37% | Upgrade
|
Operating Margin | 3.59% | 1.42% | 3.06% | 5.44% | 6.25% | Upgrade
|
Profit Margin | 0.99% | 0.69% | 0.76% | 0.85% | 0.27% | Upgrade
|
Free Cash Flow Margin | -7.97% | 1.75% | 4.09% | 13.07% | 11.75% | Upgrade
|
EBITDA | 39.96 | 36.56 | 37.77 | 51.55 | 44.55 | Upgrade
|
EBITDA Margin | 4.61% | 1.64% | 3.16% | 5.48% | 6.30% | Upgrade
|
D&A For EBITDA | 8.82 | 4.87 | 1.11 | 0.38 | 0.34 | Upgrade
|
EBIT | 31.13 | 31.69 | 36.66 | 51.17 | 44.21 | Upgrade
|
EBIT Margin | 3.59% | 1.42% | 3.06% | 5.44% | 6.25% | Upgrade
|
Effective Tax Rate | 26.39% | 40.18% | 35.82% | 27.89% | 48.74% | Upgrade
|
Revenue as Reported | 922.39 | 2,327 | 1,200 | 956.96 | 711.71 | Upgrade
|
Advertising Expenses | - | 1.03 | - | 0.38 | 0.01 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.